These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
229 related items for PubMed ID: 9918234
21. Anti-MBL autoantibodies in patients with rheumatoid arthritis: prevalence and clinical significance. Gupta B, Raghav SK, Agrawal C, Chaturvedi VP, Das RH, Das HR. J Autoimmun; 2006 Sep; 27(2):125-33. PubMed ID: 16904869 [Abstract] [Full Text] [Related]
22. Elevated levels of IgM and IgA antibodies to Proteus mirabilis and IgM antibodies to Escherichia coli are associated with early rheumatoid factor (RF)-positive rheumatoid arthritis. Newkirk MM, Goldbach-Mansky R, Senior BW, Klippel J, Schumacher HR, El-Gabalawy HS. Rheumatology (Oxford); 2005 Nov; 44(11):1433-41. PubMed ID: 16091399 [Abstract] [Full Text] [Related]
23. The role of anti-mutated citrullinated vimentin antibodies in the diagnosis of early rheumatoid arthritis. Liu X, Jia R, Zhao J, Li Z. J Rheumatol; 2009 Jun; 36(6):1136-42. PubMed ID: 19447936 [Abstract] [Full Text] [Related]
24. Multiple antibody reactivities to citrullinated antigens in sera from patients with rheumatoid arthritis: association with HLA-DRB1 alleles. Snir O, Widhe M, von Spee C, Lindberg J, Padyukov L, Lundberg K, Engström A, Venables PJ, Lundeberg J, Holmdahl R, Klareskog L, Malmström V. Ann Rheum Dis; 2009 May; 68(5):736-43. PubMed ID: 18635594 [Abstract] [Full Text] [Related]
25. Specific autoantibodies precede the symptoms of rheumatoid arthritis: a study of serial measurements in blood donors. Nielen MM, van Schaardenburg D, Reesink HW, van de Stadt RJ, van der Horst-Bruinsma IE, de Koning MH, Habibuw MR, Vandenbroucke JP, Dijkmans BA. Arthritis Rheum; 2004 Feb; 50(2):380-6. PubMed ID: 14872479 [Abstract] [Full Text] [Related]
26. [Study of the proteins associated with Sa antigen]. Chen H, Yao ZJ, Tang FL. Zhonghua Yi Xue Za Zhi; 2006 Jul 18; 86(27):1896-900. PubMed ID: 17064527 [Abstract] [Full Text] [Related]
27. Is Anti Cyclic citrullinated peptide a useful laboratory test for the diagnosis of rheumatoid arthritis? Girelli F, Foschi FG, Bedeschi E, Calderoni V, Stefanini GF, Martinelli MG. Eur Ann Allergy Clin Immunol; 2004 Apr 18; 36(4):127-30. PubMed ID: 15180353 [Abstract] [Full Text] [Related]
28. Anti-Sa antibodies and antibodies against cyclic citrullinated peptide are not equivalent as predictors of severe outcomes in patients with recent-onset polyarthritis. Boire G, Cossette P, de Brum-Fernandes AJ, Liang P, Niyonsenga T, Zhou ZJ, Carrier N, Daniel C, Ménard HA. Arthritis Res Ther; 2005 Apr 18; 7(3):R592-603. PubMed ID: 15899046 [Abstract] [Full Text] [Related]
29. Role of anticyclic citrullinated peptide in the diagnosis of early rheumatoid factor-negative suspected rheumatoid arthritis: is it worthwhile to order the test? Panchagnula R, Rajiv SR, Prakash J, Chandrashekara S, Suresh KP. J Clin Rheumatol; 2006 Aug 18; 12(4):172-5. PubMed ID: 16891919 [Abstract] [Full Text] [Related]
30. [Novel autoantibodies for the diagnosis of rheumatoid arthritis]. Steiner G, Smolen JS. Z Rheumatol; 2002 Dec 18; 61(6):667-73. PubMed ID: 12491130 [Abstract] [Full Text] [Related]
31. Presence of autoantibodies to the glycolytic enzyme alpha-enolase in sera from patients with early rheumatoid arthritis. Saulot V, Vittecoq O, Charlionet R, Fardellone P, Lange C, Marvin L, Machour N, Le Loët X, Gilbert D, Tron F. Arthritis Rheum; 2002 May 18; 46(5):1196-201. PubMed ID: 12115223 [Abstract] [Full Text] [Related]
32. Diagnostic and clinical value of anti-cyclic citrullinated peptide antibodies compared with rheumatoid factor isotypes in rheumatoid arthritis. Vallbracht I, Rieber J, Oppermann M, Förger F, Siebert U, Helmke K. Ann Rheum Dis; 2004 Sep 18; 63(9):1079-84. PubMed ID: 15308516 [Abstract] [Full Text] [Related]
33. The DERAA HLA-DR alleles in patients with early polyarthritis: protection against severe disease and lack of association with rheumatoid arthritis autoantibodies. Carrier N, Cossette P, Daniel C, de Brum-Fernandes A, Liang P, Ménard HA, Boire G. Arthritis Rheum; 2009 Mar 18; 60(3):698-707. PubMed ID: 19248090 [Abstract] [Full Text] [Related]
34. Antikeratin antibody and antiperinuclear factor as markers for subclinical rheumatoid disease process. Aho K, von Essen R, Kurki P, Palosuo T, Heliövaara M. J Rheumatol; 1993 Aug 18; 20(8):1278-81. PubMed ID: 7693940 [Abstract] [Full Text] [Related]
35. [Anti-cyclic citrullinated peptide antibodies in rheumatoid arthritis: relation with clinical features, cytokines and HLA-DRB1]. Correa PA, Tobón GJ, Citera G, Cadena J, Schneeberger E, Camargo JF, Maldonado-Cocco JA, Anaya JM. Biomedica; 2004 Jun 18; 24(2):140-52. PubMed ID: 15495594 [Abstract] [Full Text] [Related]
36. [New biomarkers for rheumatoid arthritis]. Hayashi N, Nishimura K, Kumagai S. Rinsho Byori; 2008 Apr 18; 56(4):297-308. PubMed ID: 18516964 [Abstract] [Full Text] [Related]
37. Anti-Sa antibody in Chinese rheumatoid arthritis. Xu S, Tang F, Shi L, Gan X, Shi Y, Cheng L, Li J, Dong Y. Chin Med J (Engl); 1998 Mar 18; 111(3):204-7. PubMed ID: 10374415 [Abstract] [Full Text] [Related]
38. Anti-cyclic citrullinated peptide versus anti-Sa antibodies in diagnosis of rheumatoid arthritis in an outpatient clinic for connective tissue disease and spondyloarthritis. López-Longo FJ, Rodríguez-Mahou M, Sánchez-Ramón S, Estecha A, Balsera M, Plaza R, Fernández-Cruz E, Pérez LC. J Rheumatol; 2006 Aug 18; 33(8):1476-81. PubMed ID: 16881106 [Abstract] [Full Text] [Related]
39. [New diagnostic and evaluative tests for rheumatoid arthritis]. Hayashi N, Nishimura K, Morinobu A, Kumagai S. Rinsho Byori; 2007 Apr 18; 55(4):388-96. PubMed ID: 17511271 [Abstract] [Full Text] [Related]